Vivalis EBx Proof of Concept for Production of Antibodies - Enter New Phase in Collaboration

Nantes (France) and Evry (France) - July 24th, 2007 - VIVALIS (Euronext : VLS) announce first promising data resulting from a scientific collaboration with MAT BIOPHARMA to evaluate VIVALIS EBx® cell lines for the production of MAT BIOPHARMA's monoclonal antibodies. The results confirm the strong potential of the EBx® cell lines for the monoclonal antibody market.

Back to news